Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanara MedTech Inc. - Common Stock (NQ:SMTI)

28.81 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sanara MedTech Inc. - Common Stock

< Previous 1 2 Next >
Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts
Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its... 
Via MarketMinute
Sanara MedTech Inc (NASDAQ:SMTI) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss, Shares Surge 8.4%
Sanara MedTech (SMTI) Q2 2025 earnings show revenue beat estimates with 28% YoY growth, narrowed EPS loss, and 8.4% pre-market surge. Strategic review for Tissue Health Plus underway. 
Via Chartmill
Sanara MedTech Sales Jump 28 Percent
Via The Motley Fool
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Sanara MedTech's Earnings: A Preview
 
Via Benzinga
Earnings Outlook For Sanara MedTech
 
Via Benzinga
Sanara MedTech: Q1 Earnings Insights
 
Via Benzinga
Earnings Scheduled For August 13, 2025
 
Via Benzinga
Earnings Outlook For Sanara MedTech
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Where Sanara MedTech Stands With Analysts
 
Via Benzinga
Earnings Scheduled For March 25, 2025
 
Via Benzinga
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
From Biomimetic Innovations Ltd
Via GlobeNewswire
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
SMTI stock results show that Sanara MedTech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million. 
Via Benzinga
Sanara MedTech Inc. (NASDAQ: SMTI) Highlighted for Surprising Price Action
Via Investor Brand Network
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
Earnings Scheduled For May 15, 2023
Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter. 
Via Benzinga
Sanara MedTech to Participate in Two Upcoming Healthcare Conferences
From Sanara MedTech Inc.
Via GlobeNewswire
Sanara MedTech Inc. Announces Third Quarter 2022 Results
From Sanara MedTech Inc.
Via GlobeNewswire
Sanara MedTech and InfuSystem Announce Wound Therapy Partnership
From Sanara MedTech Inc.
Via GlobeNewswire
InfuSystem and Sanara MedTech Announce Wound Therapy Partnership
From InfuSystem Holdings, Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Sanara MedTech Inc. Announces Third Quarter 2022 Earnings Release and Conference Call Dates
From Sanara MedTech Inc.
Via GlobeNewswire
Earnings Scheduled For March 30, 2022
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.